P10 Inc.'s stock plummeted 5.11% on Thursday during the intraday trading session, as the company's strong 2024 performance was overshadowed by concerns around its margin outlook for 2025.
In its Q4 2024 earnings call, P10 reported record fundraising of $3.8 billion, a 23% increase in revenue, and 17% growth in adjusted EBITDA for the full year. The company highlighted the successful closing of its Bon Accord 2 fund, which raised a record $1.6 billion, and its plans to drive further growth through acquisitions like Qualitas Funds, new product launches, and operational efficiencies.
However, analysts expressed concerns about the impact of the Qualitas acquisition on P10's fee-related earnings (FRE) margins in 2025, which the company expects to remain in the mid-40s range. Barclays lowered its price target on P10 to $15 from $16, citing the lower fee rate outlook and potential margin pressure from the Qualitas deal.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。